Precision Medicine Industry Research Report 2024
According to the National Institutes of Health (NIH), precision medicine is 'an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person.' This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a 'one-size-fits-all' approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.
Although the term 'precision medicine' is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor’s blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health in coming years.
According to APO Research, The global Precision Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
The classification of precision medicine includes diagnostics and therapies, and the proportion of diagnostics is about 67%.
Precision Medicine is used for oncology, neurosciences, immunology, respiratory and other field. The most proportion of precision medicine is for oncology, and the market share is about 30%.
Market competition is intense. Johnson & Johnson, Roche, Labcorp, Abbott Laboratories and Novartis are the leaders of the industry, with about 56% market shares.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Precision Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Medicine.
The Precision Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Precision Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Precision Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Precision Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Precision Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Precision Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Chapter 13: The main points and conclusions of the report.
Although the term 'precision medicine' is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor’s blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health in coming years.
According to APO Research, The global Precision Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
The classification of precision medicine includes diagnostics and therapies, and the proportion of diagnostics is about 67%.
Precision Medicine is used for oncology, neurosciences, immunology, respiratory and other field. The most proportion of precision medicine is for oncology, and the market share is about 30%.
Market competition is intense. Johnson & Johnson, Roche, Labcorp, Abbott Laboratories and Novartis are the leaders of the industry, with about 56% market shares.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Precision Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Medicine.
The Precision Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Precision Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Johnson & Johnson
- Roche
- Labcorp
- Abbott Laboratories
- Novartis
- Illumina
- GE Healthcare
- Intel Corporation
- Biomrieux Sa
- Cepheid
- IBM
- Qiagen
- Thermo Fisher Scientific
- Randox Laboratories
- Almac Group
- Healthcore
- Diagnostics
- Therapies
- Oncology
- Neurosciences
- Immunology
- Respiratory
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Precision Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Precision Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Precision Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Precision Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Precision Medicine by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Diagnostics
2.2.3 Therapies
2.3 Precision Medicine by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Oncology
2.3.3 Neurosciences
2.3.4 Immunology
2.3.5 Respiratory
2.3.6 Others
2.4 Assumptions and Limitations
3 PRECISION MEDICINE BREAKDOWN DATA BY TYPE
3.1 Global Precision Medicine Historic Market Size by Type (2019-2024)
3.2 Global Precision Medicine Forecasted Market Size by Type (2025-2030)
4 PRECISION MEDICINE BREAKDOWN DATA BY APPLICATION
4.1 Global Precision Medicine Historic Market Size by Application (2019-2024)
4.2 Global Precision Medicine Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Precision Medicine Market Perspective (2019-2030)
5.2 Global Precision Medicine Growth Trends by Region
5.2.1 Global Precision Medicine Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Precision Medicine Historic Market Size by Region (2019-2024)
5.2.3 Precision Medicine Forecasted Market Size by Region (2025-2030)
5.3 Precision Medicine Market Dynamics
5.3.1 Precision Medicine Industry Trends
5.3.2 Precision Medicine Market Drivers
5.3.3 Precision Medicine Market Challenges
5.3.4 Precision Medicine Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Precision Medicine Players by Revenue
6.1.1 Global Top Precision Medicine Players by Revenue (2019-2024)
6.1.2 Global Precision Medicine Revenue Market Share by Players (2019-2024)
6.2 Global Precision Medicine Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Precision Medicine Head office and Area Served
6.4 Global Precision Medicine Players, Product Type & Application
6.5 Global Precision Medicine Players, Date of Enter into This Industry
6.6 Global Precision Medicine Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Precision Medicine Market Size (2019-2030)
7.2 North America Precision Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Precision Medicine Market Size by Country (2019-2024)
7.4 North America Precision Medicine Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Precision Medicine Market Size (2019-2030)
8.2 Europe Precision Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Precision Medicine Market Size by Country (2019-2024)
8.4 Europe Precision Medicine Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Precision Medicine Market Size (2019-2030)
9.2 Asia-Pacific Precision Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Precision Medicine Market Size by Country (2019-2024)
9.4 Asia-Pacific Precision Medicine Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Precision Medicine Market Size (2019-2030)
10.2 Latin America Precision Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Precision Medicine Market Size by Country (2019-2024)
10.4 Latin America Precision Medicine Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Precision Medicine Market Size (2019-2030)
11.2 Middle East & Africa Precision Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Precision Medicine Market Size by Country (2019-2024)
11.4 Middle East & Africa Precision Medicine Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Company Information
12.1.2 Johnson & Johnson Business Overview
12.1.3 Johnson & Johnson Revenue in Precision Medicine Business (2019-2024)
12.1.4 Johnson & Johnson Precision Medicine Product Portfolio
12.1.5 Johnson & Johnson Recent Developments
12.2 Roche
12.2.1 Roche Company Information
12.2.2 Roche Business Overview
12.2.3 Roche Revenue in Precision Medicine Business (2019-2024)
12.2.4 Roche Precision Medicine Product Portfolio
12.2.5 Roche Recent Developments
12.3 Labcorp
12.3.1 Labcorp Company Information
12.3.2 Labcorp Business Overview
12.3.3 Labcorp Revenue in Precision Medicine Business (2019-2024)
12.3.4 Labcorp Precision Medicine Product Portfolio
12.3.5 Labcorp Recent Developments
12.4 Abbott Laboratories
12.4.1 Abbott Laboratories Company Information
12.4.2 Abbott Laboratories Business Overview
12.4.3 Abbott Laboratories Revenue in Precision Medicine Business (2019-2024)
12.4.4 Abbott Laboratories Precision Medicine Product Portfolio
12.4.5 Abbott Laboratories Recent Developments
12.5 Novartis
12.5.1 Novartis Company Information
12.5.2 Novartis Business Overview
12.5.3 Novartis Revenue in Precision Medicine Business (2019-2024)
12.5.4 Novartis Precision Medicine Product Portfolio
12.5.5 Novartis Recent Developments
12.6 Illumina
12.6.1 Illumina Company Information
12.6.2 Illumina Business Overview
12.6.3 Illumina Revenue in Precision Medicine Business (2019-2024)
12.6.4 Illumina Precision Medicine Product Portfolio
12.6.5 Illumina Recent Developments
12.7 GE Healthcare
12.7.1 GE Healthcare Company Information
12.7.2 GE Healthcare Business Overview
12.7.3 GE Healthcare Revenue in Precision Medicine Business (2019-2024)
12.7.4 GE Healthcare Precision Medicine Product Portfolio
12.7.5 GE Healthcare Recent Developments
12.8 Intel Corporation
12.8.1 Intel Corporation Company Information
12.8.2 Intel Corporation Business Overview
12.8.3 Intel Corporation Revenue in Precision Medicine Business (2019-2024)
12.8.4 Intel Corporation Precision Medicine Product Portfolio
12.8.5 Intel Corporation Recent Developments
12.9 Biomrieux Sa
12.9.1 Biomrieux Sa Company Information
12.9.2 Biomrieux Sa Business Overview
12.9.3 Biomrieux Sa Revenue in Precision Medicine Business (2019-2024)
12.9.4 Biomrieux Sa Precision Medicine Product Portfolio
12.9.5 Biomrieux Sa Recent Developments
12.10 Cepheid
12.10.1 Cepheid Company Information
12.10.2 Cepheid Business Overview
12.10.3 Cepheid Revenue in Precision Medicine Business (2019-2024)
12.10.4 Cepheid Precision Medicine Product Portfolio
12.10.5 Cepheid Recent Developments
12.11 IBM
12.11.1 IBM Company Information
12.11.2 IBM Business Overview
12.11.3 IBM Revenue in Precision Medicine Business (2019-2024)
12.11.4 IBM Precision Medicine Product Portfolio
12.11.5 IBM Recent Developments
12.12 Qiagen
12.12.1 Qiagen Company Information
12.12.2 Qiagen Business Overview
12.12.3 Qiagen Revenue in Precision Medicine Business (2019-2024)
12.12.4 Qiagen Precision Medicine Product Portfolio
12.12.5 Qiagen Recent Developments
12.13 Thermo Fisher Scientific
12.13.1 Thermo Fisher Scientific Company Information
12.13.2 Thermo Fisher Scientific Business Overview
12.13.3 Thermo Fisher Scientific Revenue in Precision Medicine Business (2019-2024)
12.13.4 Thermo Fisher Scientific Precision Medicine Product Portfolio
12.13.5 Thermo Fisher Scientific Recent Developments
12.14 Randox Laboratories
12.14.1 Randox Laboratories Company Information
12.14.2 Randox Laboratories Business Overview
12.14.3 Randox Laboratories Revenue in Precision Medicine Business (2019-2024)
12.14.4 Randox Laboratories Precision Medicine Product Portfolio
12.14.5 Randox Laboratories Recent Developments
12.15 Almac Group
12.15.1 Almac Group Company Information
12.15.2 Almac Group Business Overview
12.15.3 Almac Group Revenue in Precision Medicine Business (2019-2024)
12.15.4 Almac Group Precision Medicine Product Portfolio
12.15.5 Almac Group Recent Developments
12.16 Healthcore
12.16.1 Healthcore Company Information
12.16.2 Healthcore Business Overview
12.16.3 Healthcore Revenue in Precision Medicine Business (2019-2024)
12.16.4 Healthcore Precision Medicine Product Portfolio
12.16.5 Healthcore Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Precision Medicine by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Diagnostics
2.2.3 Therapies
2.3 Precision Medicine by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Oncology
2.3.3 Neurosciences
2.3.4 Immunology
2.3.5 Respiratory
2.3.6 Others
2.4 Assumptions and Limitations
3 PRECISION MEDICINE BREAKDOWN DATA BY TYPE
3.1 Global Precision Medicine Historic Market Size by Type (2019-2024)
3.2 Global Precision Medicine Forecasted Market Size by Type (2025-2030)
4 PRECISION MEDICINE BREAKDOWN DATA BY APPLICATION
4.1 Global Precision Medicine Historic Market Size by Application (2019-2024)
4.2 Global Precision Medicine Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Precision Medicine Market Perspective (2019-2030)
5.2 Global Precision Medicine Growth Trends by Region
5.2.1 Global Precision Medicine Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Precision Medicine Historic Market Size by Region (2019-2024)
5.2.3 Precision Medicine Forecasted Market Size by Region (2025-2030)
5.3 Precision Medicine Market Dynamics
5.3.1 Precision Medicine Industry Trends
5.3.2 Precision Medicine Market Drivers
5.3.3 Precision Medicine Market Challenges
5.3.4 Precision Medicine Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Precision Medicine Players by Revenue
6.1.1 Global Top Precision Medicine Players by Revenue (2019-2024)
6.1.2 Global Precision Medicine Revenue Market Share by Players (2019-2024)
6.2 Global Precision Medicine Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Precision Medicine Head office and Area Served
6.4 Global Precision Medicine Players, Product Type & Application
6.5 Global Precision Medicine Players, Date of Enter into This Industry
6.6 Global Precision Medicine Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Precision Medicine Market Size (2019-2030)
7.2 North America Precision Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Precision Medicine Market Size by Country (2019-2024)
7.4 North America Precision Medicine Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Precision Medicine Market Size (2019-2030)
8.2 Europe Precision Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Precision Medicine Market Size by Country (2019-2024)
8.4 Europe Precision Medicine Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Precision Medicine Market Size (2019-2030)
9.2 Asia-Pacific Precision Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Precision Medicine Market Size by Country (2019-2024)
9.4 Asia-Pacific Precision Medicine Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Precision Medicine Market Size (2019-2030)
10.2 Latin America Precision Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Precision Medicine Market Size by Country (2019-2024)
10.4 Latin America Precision Medicine Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Precision Medicine Market Size (2019-2030)
11.2 Middle East & Africa Precision Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Precision Medicine Market Size by Country (2019-2024)
11.4 Middle East & Africa Precision Medicine Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Company Information
12.1.2 Johnson & Johnson Business Overview
12.1.3 Johnson & Johnson Revenue in Precision Medicine Business (2019-2024)
12.1.4 Johnson & Johnson Precision Medicine Product Portfolio
12.1.5 Johnson & Johnson Recent Developments
12.2 Roche
12.2.1 Roche Company Information
12.2.2 Roche Business Overview
12.2.3 Roche Revenue in Precision Medicine Business (2019-2024)
12.2.4 Roche Precision Medicine Product Portfolio
12.2.5 Roche Recent Developments
12.3 Labcorp
12.3.1 Labcorp Company Information
12.3.2 Labcorp Business Overview
12.3.3 Labcorp Revenue in Precision Medicine Business (2019-2024)
12.3.4 Labcorp Precision Medicine Product Portfolio
12.3.5 Labcorp Recent Developments
12.4 Abbott Laboratories
12.4.1 Abbott Laboratories Company Information
12.4.2 Abbott Laboratories Business Overview
12.4.3 Abbott Laboratories Revenue in Precision Medicine Business (2019-2024)
12.4.4 Abbott Laboratories Precision Medicine Product Portfolio
12.4.5 Abbott Laboratories Recent Developments
12.5 Novartis
12.5.1 Novartis Company Information
12.5.2 Novartis Business Overview
12.5.3 Novartis Revenue in Precision Medicine Business (2019-2024)
12.5.4 Novartis Precision Medicine Product Portfolio
12.5.5 Novartis Recent Developments
12.6 Illumina
12.6.1 Illumina Company Information
12.6.2 Illumina Business Overview
12.6.3 Illumina Revenue in Precision Medicine Business (2019-2024)
12.6.4 Illumina Precision Medicine Product Portfolio
12.6.5 Illumina Recent Developments
12.7 GE Healthcare
12.7.1 GE Healthcare Company Information
12.7.2 GE Healthcare Business Overview
12.7.3 GE Healthcare Revenue in Precision Medicine Business (2019-2024)
12.7.4 GE Healthcare Precision Medicine Product Portfolio
12.7.5 GE Healthcare Recent Developments
12.8 Intel Corporation
12.8.1 Intel Corporation Company Information
12.8.2 Intel Corporation Business Overview
12.8.3 Intel Corporation Revenue in Precision Medicine Business (2019-2024)
12.8.4 Intel Corporation Precision Medicine Product Portfolio
12.8.5 Intel Corporation Recent Developments
12.9 Biomrieux Sa
12.9.1 Biomrieux Sa Company Information
12.9.2 Biomrieux Sa Business Overview
12.9.3 Biomrieux Sa Revenue in Precision Medicine Business (2019-2024)
12.9.4 Biomrieux Sa Precision Medicine Product Portfolio
12.9.5 Biomrieux Sa Recent Developments
12.10 Cepheid
12.10.1 Cepheid Company Information
12.10.2 Cepheid Business Overview
12.10.3 Cepheid Revenue in Precision Medicine Business (2019-2024)
12.10.4 Cepheid Precision Medicine Product Portfolio
12.10.5 Cepheid Recent Developments
12.11 IBM
12.11.1 IBM Company Information
12.11.2 IBM Business Overview
12.11.3 IBM Revenue in Precision Medicine Business (2019-2024)
12.11.4 IBM Precision Medicine Product Portfolio
12.11.5 IBM Recent Developments
12.12 Qiagen
12.12.1 Qiagen Company Information
12.12.2 Qiagen Business Overview
12.12.3 Qiagen Revenue in Precision Medicine Business (2019-2024)
12.12.4 Qiagen Precision Medicine Product Portfolio
12.12.5 Qiagen Recent Developments
12.13 Thermo Fisher Scientific
12.13.1 Thermo Fisher Scientific Company Information
12.13.2 Thermo Fisher Scientific Business Overview
12.13.3 Thermo Fisher Scientific Revenue in Precision Medicine Business (2019-2024)
12.13.4 Thermo Fisher Scientific Precision Medicine Product Portfolio
12.13.5 Thermo Fisher Scientific Recent Developments
12.14 Randox Laboratories
12.14.1 Randox Laboratories Company Information
12.14.2 Randox Laboratories Business Overview
12.14.3 Randox Laboratories Revenue in Precision Medicine Business (2019-2024)
12.14.4 Randox Laboratories Precision Medicine Product Portfolio
12.14.5 Randox Laboratories Recent Developments
12.15 Almac Group
12.15.1 Almac Group Company Information
12.15.2 Almac Group Business Overview
12.15.3 Almac Group Revenue in Precision Medicine Business (2019-2024)
12.15.4 Almac Group Precision Medicine Product Portfolio
12.15.5 Almac Group Recent Developments
12.16 Healthcore
12.16.1 Healthcore Company Information
12.16.2 Healthcore Business Overview
12.16.3 Healthcore Revenue in Precision Medicine Business (2019-2024)
12.16.4 Healthcore Precision Medicine Product Portfolio
12.16.5 Healthcore Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
